These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15823491)

  • 1. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease.
    Matsuzawa Y
    Atheroscler Suppl; 2005 May; 6(2):7-14. PubMed ID: 15823491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin: a key adipocytokine in metabolic syndrome.
    Okamoto Y; Kihara S; Funahashi T; Matsuzawa Y; Libby P
    Clin Sci (Lond); 2006 Mar; 110(3):267-78. PubMed ID: 16464169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the novel adipocyte-derived hormone adiponectin in human disease.
    Díez JJ; Iglesias P
    Eur J Endocrinol; 2003 Mar; 148(3):293-300. PubMed ID: 12611609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adiponectin in metabolic and vascular disease: a review.
    Cui J; Panse S; Falkner B
    Clin Nephrol; 2011 Jan; 75(1):26-33. PubMed ID: 21176748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C; Fu Y; Chung BH; Garvey WT
    Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
    Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
    J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular actions of adiponectin: pathophysiologic implications.
    Maia-Fernandes T; Roncon-Albuquerque R; Leite-Moreira AF
    Rev Port Cardiol; 2008 Nov; 27(11):1431-49. PubMed ID: 19227810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
    Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
    Matsuda M; Shimomura I
    Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
    Yamauchi T; Kadowaki T
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum adiponectin is related to plasma high-density lipoprotein cholesterol but not to plasma insulin-concentration in healthy children: the FLVS II study.
    Kettaneh A; Heude B; Oppert JM; Scherer P; Meyre D; Borys JM; Ducimetiere P; Charles MA
    Metabolism; 2006 Sep; 55(9):1171-6. PubMed ID: 16919535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adiponectin--adipocytokine with a broad clinical spectrum].
    Szopa M; Malczewska-Malec M; Wybrańska I; Kieć-Wilk B; Bodzioch M; Trzos M; Dembińska-Kieć A
    Przegl Lek; 2004; 61(2):109-14. PubMed ID: 15230153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
    Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
    Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
    Goto T; Teraminami A; Lee JY; Ohyama K; Funakoshi K; Kim YI; Hirai S; Uemura T; Yu R; Takahashi N; Kawada T
    J Nutr Biochem; 2012 Jul; 23(7):768-76. PubMed ID: 21889885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children.
    Chu NF; Shen MH; Wu DM; Lai CJ
    Obes Res; 2005 Nov; 13(11):2014-20. PubMed ID: 16339134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
    Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
    Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
    Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
    Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.